Italy Healthcare, Regulatory and Reimbursement Landscape Report 2016 - Industry Value Will Drop to $18.6 Billion by 2020 due to Struggling Economy - Research and Markets

Research and Markets has announced the addition of the "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy" report to their offering.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and the country's healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the Italian pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by a team of industry experts.

Italy's Pharmaceutical Industry Value Will Drop to $18.6 Billion by 2020 due to Struggling Economy.

The pharmaceutical industry in Italy is set to decline from $21.3 billion in 2016 to $18.6 billion by 2020, at a negative compound annual growth rate of 3.3%, primarily due to the country's struggling economy.

The company's latest report* states that the strict pricing of drugs through negotiations and external and internal reference pricing is a barrier to the launch of innovative molecules, and that sales of generics and over-the-counter drugs will increase over the forecast period.

The pharmaceutical industry in Italy will face a number of challenges over the next few years. An increase in the Italian government's debt relative to GDP, and the country's poor growth record, will decrease cash flow in the country, meaning the industry will stagnate.

The Italian economy is also vulnerable to fluctuations in the demand and supply of goods and services in other countries. The Eurozone crisis is likely to result in lower demand for Italian products from other European countries, reducing exports and engendering a hostile environment for innovation or investment. India and China also present a threat as they have an edge in the generics market, and may usurp sales away from Italy's domestic pharmaceutical space.

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Overview of Pharmaceutical and Medical Device Markets

3.1 Pharmaceutical Market

3.2 Medical Device Market

3.3 Market Drivers and Barriers

4 Market Access

4.1 Reimbursement and Payer Landscape

4.2 Regulatory Landscape

5 Country Analysis

5.1 Political Environment

5.2 Economic Landscape

5.3 Economic Indicators

5.4 Demographics

5.5 Healthcare Infrastructure

5.6 Healthcare Expenditure

5.7 Trade Associations

5.8 Trade Fairs

6 Opportunities and Challenges

7 Appendix

For more information visit http://www.researchandmarkets.com/research/wxm6zg/countryfocus

View source version on businesswire.com: http://www.businesswire.com/news/home/20160526006206/en/